pubmed-article:2920827 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:2920827 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
pubmed-article:2920827 | lifeskim:mentions | umls-concept:C0040478 | lld:lifeskim |
pubmed-article:2920827 | lifeskim:mentions | umls-concept:C0033684 | lld:lifeskim |
pubmed-article:2920827 | lifeskim:mentions | umls-concept:C1167384 | lld:lifeskim |
pubmed-article:2920827 | lifeskim:mentions | umls-concept:C0027138 | lld:lifeskim |
pubmed-article:2920827 | lifeskim:mentions | umls-concept:C0332206 | lld:lifeskim |
pubmed-article:2920827 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:2920827 | pubmed:dateCreated | 1989-4-7 | lld:pubmed |
pubmed-article:2920827 | pubmed:abstractText | The NH2-terminal blocking group of the 43-kDa peripheral membrane protein (43-kDa protein) of Torpedo post-synaptic membranes has been identified as myristic acid. To identify that blocking group pure 43-kDa protein was digested with trypsin and the blocked tryptic peptide was isolated by reverse phase HPLC. That peptide coeluted with and had the same amino acid composition as a synthetic peptide, myristoyl-Gly-Gln-Asp-Gln-Thr-Lys, the structure of the amino terminus predicted from the protein sequence deduced from a cDNA clone. The presence of myristate was confirmed by the precise molecular mass of the peptide, 886.5266, determined by fast atom bombardment mass spectroscopy. | lld:pubmed |
pubmed-article:2920827 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2920827 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2920827 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2920827 | pubmed:language | eng | lld:pubmed |
pubmed-article:2920827 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2920827 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:2920827 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2920827 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2920827 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2920827 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2920827 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2920827 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2920827 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2920827 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2920827 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:2920827 | pubmed:month | Jan | lld:pubmed |
pubmed-article:2920827 | pubmed:issn | 0014-5793 | lld:pubmed |
pubmed-article:2920827 | pubmed:author | pubmed-author:CohenJ BJB | lld:pubmed |
pubmed-article:2920827 | pubmed:author | pubmed-author:CarrCC | lld:pubmed |
pubmed-article:2920827 | pubmed:author | pubmed-author:TylerA NAN | lld:pubmed |
pubmed-article:2920827 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:2920827 | pubmed:day | 16 | lld:pubmed |
pubmed-article:2920827 | pubmed:volume | 243 | lld:pubmed |
pubmed-article:2920827 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:2920827 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:2920827 | pubmed:pagination | 65-9 | lld:pubmed |
pubmed-article:2920827 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:2920827 | pubmed:meshHeading | pubmed-meshheading:2920827-... | lld:pubmed |
pubmed-article:2920827 | pubmed:meshHeading | pubmed-meshheading:2920827-... | lld:pubmed |
pubmed-article:2920827 | pubmed:meshHeading | pubmed-meshheading:2920827-... | lld:pubmed |
pubmed-article:2920827 | pubmed:meshHeading | pubmed-meshheading:2920827-... | lld:pubmed |
pubmed-article:2920827 | pubmed:meshHeading | pubmed-meshheading:2920827-... | lld:pubmed |
pubmed-article:2920827 | pubmed:meshHeading | pubmed-meshheading:2920827-... | lld:pubmed |
pubmed-article:2920827 | pubmed:meshHeading | pubmed-meshheading:2920827-... | lld:pubmed |
pubmed-article:2920827 | pubmed:meshHeading | pubmed-meshheading:2920827-... | lld:pubmed |
pubmed-article:2920827 | pubmed:meshHeading | pubmed-meshheading:2920827-... | lld:pubmed |
pubmed-article:2920827 | pubmed:meshHeading | pubmed-meshheading:2920827-... | lld:pubmed |
pubmed-article:2920827 | pubmed:meshHeading | pubmed-meshheading:2920827-... | lld:pubmed |
pubmed-article:2920827 | pubmed:meshHeading | pubmed-meshheading:2920827-... | lld:pubmed |
pubmed-article:2920827 | pubmed:meshHeading | pubmed-meshheading:2920827-... | lld:pubmed |
pubmed-article:2920827 | pubmed:year | 1989 | lld:pubmed |
pubmed-article:2920827 | pubmed:articleTitle | Myristic acid is the NH2-terminal blocking group of the 43-kDa protein of Torpedo nicotinic post-synaptic membranes. | lld:pubmed |
pubmed-article:2920827 | pubmed:affiliation | Department of Anatomy, Washington University School of Medicine, St. Louis, MO 63110. | lld:pubmed |
pubmed-article:2920827 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:2920827 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:2920827 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2920827 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2920827 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2920827 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2920827 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2920827 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2920827 | lld:pubmed |